Behrman Capital invests in Emmes Corp

Behrman Capital said March that it invested the Emmes Corp. Financial terms weren’t announced. Emmes is a contract research organization that partners with government, private foundation, and commercial clients to develop treatments for diseases and disorders impacting public health.

DealsNorth AmericaUSBriefs